SM Galbraith, RJ Maxwell,
MA Lodge… - Journal of clinical …, 2003 - ascopubs.org
Purpose: Combretastatin A4 phosphate (CA4P) is a novel vascular targeting agent. Dynamic
contrast enhanced magnetic resonance imaging (DCE-MRI) studies were performed to …